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RelapseAbstract Introduction: This is a case report of pleural effusion with acute drug reactions to anti-
tubercular drugs.
Case presentation: A 45 year old female patient had the typical signs and symptoms of tubercu-
losis with continuous coughing, breathlessness and protruded abdomen. The USG abdomen
showed fluid in the left pleural space. Thoracocentesis was carried out thrice at an interval of
15 days and about 5.15 L were aspirated. The symptoms of dyspnea and cough were relieved. There
was acute drug reaction after starting the ATT. The blood pressure was very high requiring hospital
admission. The patient was monitored during the entire course of treatment. No fluid in the bilat-
eral pleural spaces was observed in USG after 6 months of treatment.
This patient had spinal tuberculosis 8 years ago and had recovered following ATT. Therefore, it
is difficult to say whether pleural effusion was due to relapse of a previous infection or a
re-infection. It is also not known whether TB patients remain susceptible to yet another infection
in some other extra-pulmonary site.
Conclusion: Abdominal TB should be suspected in patients with fever, abdominal pain and
ascites. Sputum induction (in addition to pleural fluid) for acid-fast bacilli and culture is a recom-
mended procedure in all patients with TB pleurisy.
This condition carries good prognosis, if promptly diagnosed and treated. A reasonable manage-
ment strategy for pleural TB would be to initiate a four-drug regimen and perform a therapeutic
thoracocentesis in patients with large, symptomatic effusions. Prolonged follow-up is essential in
cases of pleural effusion, as in the presented case.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).91 562
Figures 1 and 2 The left pleural effusion of the patient.
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Consent
A written informed consent was obtained from the patient for
publication of this case report and accompanying images.
Case presentation
This is a case of pleural effusion due to tuberculosis. A 45 year
old female patient had the following signs and symptoms. She
was having low grade night fever, weight loss of 3–4 kgs, and
cough that lasted. The fever and cough continued even after
standard antibiotics and paracetamol for 2 weeks. This was fol-
lowed by breathlessness, protruded abdomen, discomfort while
sleeping, etc. This condition resulted in feeling ashamed while
going out. Every day, the abdomen looked even more bigger
until one day a reddish outline was observed. The abdomen
appeared tight to touch, stretched and shiny. The patient
coughed continuously and breathing sounds could be heard
while lying down. The doctor advised ultrasonography
(USG) along with other tests. USG abdomen showed fluid in
left pleural space (Figs. 1 and 2). Thoracocentesis was advised
and was carried out thrice at an interval of 15 days and about
5.15 L [2.5 L, 2.2 L and 450 ml fluid at each sitting] were aspi-
rated. The symptoms of dyspnea and cough were relieved. The
fluid was sent for Gram staining and culture and TB markers
(adenosine deaminase >45 IU/L). Cytology revealed plenty
of lymphocytes and occasional macrophages but mesothelial/
malignant cells were not found. FNAC of supra-clavicular
nodule showed blood only. ADA of pleural fluid was
84 U/L [normal <30 U/L, suspect 30–4 U/L, strong suspect
>40–<60, positive >60 U/L]. Uric acid – 8.69, cholesterol –
222, Urea – 39 mg/dl, creatinine – 1.4, bilirubin – 0.2, total
bilirubin – 0.9, SGOT (AST) – 48 [5–40 IU/L], SGPT (ALT)
– 43 [5–50 IU/L], serum alkaline phosphatase – 432 IU/L
[100–300 IU/L]. The smear of pleural fluid showed few pus cells
but no bacteria. The protein content was 5.8 g/dl and LDH was
368 U/L [250–450]. Anti-TB treatment was started. A few
weeks after starting the ATT, there was severe drug reaction
followed by vomiting. The blood pressure was very high. The
patient was admitted in the TB ward and anti-hypertensives
as well as diuretics were administered. The patient became
stable after 12 h and all blood tests were normal. A fresh batch
of ATT drugs along with multi-vitamins were administered and
the patient was discharged from the ward after a week. The
treatment continued for 6 months and the patient was advised
X-ray, DC, TLC, LFT, Hb and USG after completion of treat-
ment. USG abdomen revealed no fluid in the bilateral pleural
spaces and all other parameters of blood tests were within
normal range.
This patient had spinal tuberculosis about 8 years ago,
wherein lytic areas of bone destruction in D9, D10, D11 and
L2, L3, L5 vertebral bodies were observed in CT scan images.
Hypodense collection was seen in the pre- and para- vertebral
spaces at D9–D11 levels. She was treated with standard
anti-tuberculosis treatment, advised bed rest, restricted move-
ment and good nutritional support along with lumbo-sacral
braces while ambulant and recovered from grade III paraple-
gia [16].Discussion
Pleural effusion is defined as an abnormal accumulation of
fluid in the pleural space. It is not a disease but rather a com-
plication of an underlying illness [1,2]. Excess fluid results from
the disruption of the equilibrium that exists across pleural
membranes. Pleural effusion is an indicator of a pathologic
process that may be of primary pulmonary origin or of an ori-
gin related to another organ system or to systemic disease [3,4].
It may occur in the setting of acute or chronic disease and is
not a diagnosis in itself [5,6].
It is a common clinical finding with a wide range of causes,
but develops most frequently as a part of the decompensation
of previously asymptomatic chronic liver disease. The clinical
manifestations of ascites vary from an asymptomatic patient
to patients complaining of increased abdominal girth, early
satiety, and respiratory distress depending on the amount of
fluid accumulated in the abdomen [7]. On physical examina-
tion the presence of ascites is suggested by the following find-
ings: abdominal distension, bulging flanks, tympany of the top,
fluid wave, shifting dullness, puddle sign.
Ultrasonography is performed to detect or exclude the pres-
ence of fluid, if the physical examination is not definitive, since
abdominal USG can detect small amounts of fluid as 100 ml
[8]. In thoracocentesis procedure, a needle is inserted through
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costal space on the mid-axillary line, into the pleural space and
fluid is drained. The fluid is then evaluated for the chemical
composition including protein, lactate dehydrogenase (LDH),
albumin, amylase, pH, glucose, Gram stain and culture to
identify possible bacterial infections, cell count and differen-
tial, cytopathology to identify cancer cells, some infective
organisms and other tests as suggested by the clinical situation
namely lipids, fungal culture, viral culture and specific
immunoglobulins [9–13].
Tuberculous pleural effusion is one of the most common
forms of extra-pulmonary tuberculosis (TB). The immediate
cause of the effusion is a delayed hypersensitivity response to
mycobacterial antigens in the pleural space. Abdominal para-
centesis with analysis of the ascitic fluid should be done in
patients with new onset ascites, those requiring hospitalization
because of ascites and those whose condition deteriorates dur-
ing hospitalization [14]. In areas with high TB prevalence,
pleural fluid adenosine deaminase (ADA) levels greater than
40 U/l argue strongly for TB; in contrast, low levels of pleural
ADA have high negative predictive value in low-prevalence
countries [15]. The specificity of this enzyme increases if only
lymphocytic exudates are considered. The shortcoming of the
ADA test is its inability to provide culture and drug sensitivity
information, which is paramount in countries with a high
degree of resistance to anti-TB drugs. This patient had spinal
tuberculosis about 8 years ago and had recovered following
ATT [16]. Therefore, it is difficult to say whether pleural effu-
sion was due to relapse of previous infection or a re-infection.
It is also not known whether TB patients remain susceptible to
yet another infection in some other extra-pulmonary site.
Sputum induction (in addition to pleural fluid) for acid-fast
bacilli and culture is a recommended procedure in all patients
with TB pleurisy. Abdominal TB should be suspected in
patients with fever, abdominal pain and ascites. This condition
carries good prognosis, if promptly diagnosed and treated
[17–19]. A reasonable management strategy for pleural TB
would be to initiate a four-drug regimen and perform a thera-
peutic thoracocentesis in patients with large, symptomatic
effusions.
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